Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 21 |
NetGPI | no | yes: 0, no: 21 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 1 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AH76
Term | Name | Level | Count |
---|---|---|---|
GO:0006479 | protein methylation | 4 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0008213 | protein alkylation | 5 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016570 | histone modification | 5 | 1 |
GO:0016571 | histone methylation | 5 | 1 |
GO:0018022 | peptidyl-lysine methylation | 5 | 1 |
GO:0018193 | peptidyl-amino acid modification | 5 | 1 |
GO:0018205 | peptidyl-lysine modification | 6 | 1 |
GO:0019538 | protein metabolic process | 3 | 1 |
GO:0032259 | methylation | 2 | 1 |
GO:0034968 | histone lysine methylation | 6 | 1 |
GO:0036211 | protein modification process | 4 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0043414 | macromolecule methylation | 3 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
GO:0009892 | negative regulation of metabolic process | 4 | 1 |
GO:0010468 | regulation of gene expression | 5 | 1 |
GO:0010605 | negative regulation of macromolecule metabolic process | 5 | 1 |
GO:0010629 | negative regulation of gene expression | 6 | 1 |
GO:0019222 | regulation of metabolic process | 3 | 1 |
GO:0040029 | epigenetic regulation of gene expression | 6 | 1 |
GO:0045814 | negative regulation of gene expression, epigenetic | 7 | 1 |
GO:0048519 | negative regulation of biological process | 3 | 1 |
GO:0050789 | regulation of biological process | 2 | 1 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 9 |
GO:0043167 | ion binding | 2 | 9 |
GO:0043169 | cation binding | 3 | 9 |
GO:0046872 | metal ion binding | 4 | 9 |
GO:0003824 | catalytic activity | 1 | 2 |
GO:0008168 | methyltransferase activity | 4 | 2 |
GO:0008170 | N-methyltransferase activity | 5 | 2 |
GO:0008276 | protein methyltransferase activity | 3 | 2 |
GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity | 5 | 2 |
GO:0016278 | lysine N-methyltransferase activity | 6 | 2 |
GO:0016279 | protein-lysine N-methyltransferase activity | 4 | 2 |
GO:0016740 | transferase activity | 2 | 2 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 2 |
GO:0018024 | obsolete histone lysine N-methyltransferase activity | 5 | 2 |
GO:0042054 | histone methyltransferase activity | 4 | 2 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 2 |
GO:0042799 | histone H4K20 methyltransferase activity | 6 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 365 | 367 | PF00675 | 0.451 |
CLV_NRD_NRD_1 | 377 | 379 | PF00675 | 0.414 |
CLV_NRD_NRD_1 | 71 | 73 | PF00675 | 0.502 |
CLV_PCSK_KEX2_1 | 17 | 19 | PF00082 | 0.401 |
CLV_PCSK_KEX2_1 | 365 | 367 | PF00082 | 0.417 |
CLV_PCSK_KEX2_1 | 377 | 379 | PF00082 | 0.475 |
CLV_PCSK_KEX2_1 | 71 | 73 | PF00082 | 0.527 |
CLV_PCSK_PC1ET2_1 | 17 | 19 | PF00082 | 0.458 |
CLV_PCSK_SKI1_1 | 100 | 104 | PF00082 | 0.499 |
CLV_PCSK_SKI1_1 | 263 | 267 | PF00082 | 0.311 |
CLV_PCSK_SKI1_1 | 311 | 315 | PF00082 | 0.280 |
DOC_CDC14_PxL_1 | 345 | 353 | PF14671 | 0.541 |
DOC_CKS1_1 | 29 | 34 | PF01111 | 0.491 |
DOC_CYCLIN_yCln2_LP_2 | 46 | 52 | PF00134 | 0.386 |
DOC_MAPK_gen_1 | 191 | 200 | PF00069 | 0.567 |
DOC_MAPK_MEF2A_6 | 193 | 202 | PF00069 | 0.553 |
DOC_MAPK_MEF2A_6 | 301 | 309 | PF00069 | 0.494 |
DOC_PP1_RVXF_1 | 251 | 257 | PF00149 | 0.480 |
DOC_PP2B_LxvP_1 | 307 | 310 | PF13499 | 0.532 |
DOC_PP4_FxxP_1 | 98 | 101 | PF00568 | 0.511 |
DOC_USP7_MATH_1 | 127 | 131 | PF00917 | 0.542 |
DOC_USP7_MATH_1 | 157 | 161 | PF00917 | 0.556 |
DOC_USP7_MATH_1 | 76 | 80 | PF00917 | 0.509 |
DOC_WW_Pin1_4 | 254 | 259 | PF00397 | 0.494 |
DOC_WW_Pin1_4 | 28 | 33 | PF00397 | 0.449 |
LIG_14-3-3_CanoR_1 | 121 | 127 | PF00244 | 0.491 |
LIG_14-3-3_CanoR_1 | 128 | 132 | PF00244 | 0.462 |
LIG_14-3-3_CanoR_1 | 253 | 257 | PF00244 | 0.500 |
LIG_14-3-3_CanoR_1 | 293 | 299 | PF00244 | 0.510 |
LIG_14-3-3_CanoR_1 | 329 | 337 | PF00244 | 0.486 |
LIG_ActinCP_TwfCPI_2 | 98 | 105 | PF01115 | 0.510 |
LIG_APCC_ABBA_1 | 281 | 286 | PF00400 | 0.437 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.537 |
LIG_EVH1_2 | 32 | 36 | PF00568 | 0.424 |
LIG_FHA_1 | 271 | 277 | PF00498 | 0.539 |
LIG_FHA_1 | 302 | 308 | PF00498 | 0.562 |
LIG_FHA_1 | 332 | 338 | PF00498 | 0.485 |
LIG_FHA_1 | 358 | 364 | PF00498 | 0.470 |
LIG_FHA_2 | 29 | 35 | PF00498 | 0.422 |
LIG_FHA_2 | 331 | 337 | PF00498 | 0.461 |
LIG_LIR_Gen_1 | 194 | 203 | PF02991 | 0.502 |
LIG_LIR_Nem_3 | 136 | 142 | PF02991 | 0.511 |
LIG_LIR_Nem_3 | 194 | 198 | PF02991 | 0.526 |
LIG_LYPXL_yS_3 | 348 | 351 | PF13949 | 0.423 |
LIG_PCNA_yPIPBox_3 | 218 | 231 | PF02747 | 0.510 |
LIG_SH2_NCK_1 | 56 | 60 | PF00017 | 0.401 |
LIG_SH2_STAP1 | 284 | 288 | PF00017 | 0.490 |
LIG_SH2_STAT5 | 151 | 154 | PF00017 | 0.437 |
LIG_SH2_STAT5 | 172 | 175 | PF00017 | 0.474 |
LIG_SH2_STAT5 | 50 | 53 | PF00017 | 0.376 |
LIG_SH3_3 | 132 | 138 | PF00018 | 0.526 |
LIG_SH3_3 | 26 | 32 | PF00018 | 0.489 |
LIG_TRAF2_1 | 143 | 146 | PF00917 | 0.547 |
LIG_TRAF2_1 | 283 | 286 | PF00917 | 0.480 |
MOD_CK1_1 | 90 | 96 | PF00069 | 0.513 |
MOD_CK2_1 | 152 | 158 | PF00069 | 0.560 |
MOD_CK2_1 | 164 | 170 | PF00069 | 0.539 |
MOD_CK2_1 | 28 | 34 | PF00069 | 0.451 |
MOD_GlcNHglycan | 241 | 244 | PF01048 | 0.281 |
MOD_GlcNHglycan | 250 | 253 | PF01048 | 0.278 |
MOD_GlcNHglycan | 65 | 68 | PF01048 | 0.467 |
MOD_GSK3_1 | 147 | 154 | PF00069 | 0.515 |
MOD_GSK3_1 | 157 | 164 | PF00069 | 0.513 |
MOD_GSK3_1 | 248 | 255 | PF00069 | 0.527 |
MOD_GSK3_1 | 76 | 83 | PF00069 | 0.535 |
MOD_LATS_1 | 69 | 75 | PF00433 | 0.365 |
MOD_N-GLC_1 | 164 | 169 | PF02516 | 0.339 |
MOD_N-GLC_1 | 314 | 319 | PF02516 | 0.282 |
MOD_NEK2_1 | 103 | 108 | PF00069 | 0.410 |
MOD_NEK2_1 | 261 | 266 | PF00069 | 0.484 |
MOD_NEK2_1 | 314 | 319 | PF00069 | 0.500 |
MOD_OFUCOSY | 163 | 168 | PF10250 | 0.339 |
MOD_PIKK_1 | 80 | 86 | PF00454 | 0.422 |
MOD_PKA_1 | 71 | 77 | PF00069 | 0.368 |
MOD_PKA_2 | 120 | 126 | PF00069 | 0.524 |
MOD_PKA_2 | 127 | 133 | PF00069 | 0.527 |
MOD_PKA_2 | 252 | 258 | PF00069 | 0.546 |
MOD_PKA_2 | 270 | 276 | PF00069 | 0.374 |
MOD_PKA_2 | 292 | 298 | PF00069 | 0.475 |
MOD_PKA_2 | 63 | 69 | PF00069 | 0.595 |
MOD_PKA_2 | 71 | 77 | PF00069 | 0.566 |
MOD_Plk_1 | 157 | 163 | PF00069 | 0.539 |
MOD_Plk_2-3 | 194 | 200 | PF00069 | 0.465 |
MOD_Plk_4 | 277 | 283 | PF00069 | 0.496 |
MOD_Plk_4 | 58 | 64 | PF00069 | 0.503 |
MOD_ProDKin_1 | 254 | 260 | PF00069 | 0.494 |
MOD_ProDKin_1 | 28 | 34 | PF00069 | 0.448 |
TRG_ENDOCYTIC_2 | 195 | 198 | PF00928 | 0.553 |
TRG_ENDOCYTIC_2 | 269 | 272 | PF00928 | 0.480 |
TRG_ENDOCYTIC_2 | 284 | 287 | PF00928 | 0.480 |
TRG_ENDOCYTIC_2 | 348 | 351 | PF00928 | 0.422 |
TRG_ENDOCYTIC_2 | 43 | 46 | PF00928 | 0.398 |
TRG_ENDOCYTIC_2 | 50 | 53 | PF00928 | 0.372 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P571 | Leptomonas seymouri | 29% | 79% |
A0A0N0P874 | Leptomonas seymouri | 76% | 100% |
A0A0S4JLZ8 | Bodo saltans | 48% | 100% |
A0A0S4JRV8 | Bodo saltans | 26% | 83% |
A0A1X0NL17 | Trypanosomatidae | 32% | 84% |
A0A1X0NXF7 | Trypanosomatidae | 56% | 100% |
A0A3R7KQ99 | Trypanosoma rangeli | 29% | 88% |
A0A3S7WPJ6 | Leishmania donovani | 24% | 76% |
A0A3S7WYH0 | Leishmania donovani | 99% | 100% |
A4H4R3 | Leishmania braziliensis | 26% | 75% |
A4HDM9 | Leishmania braziliensis | 90% | 100% |
A4HSZ2 | Leishmania infantum | 24% | 76% |
C9ZTM3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 28% | 88% |
C9ZWD6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 60% | 100% |
E9AKX9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 25% | 77% |
E9AX14 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 96% | 100% |
Q4QAG2 | Leishmania major | 97% | 100% |
Q4QIX6 | Leishmania major | 26% | 76% |
V5AVL1 | Trypanosoma cruzi | 60% | 100% |
V5BT58 | Trypanosoma cruzi | 32% | 88% |